Literature DB >> 17420393

Liquid crystal glasses: feasibility and safety of a new modality for treating amblyopia.

Omry BenEzra, Rafi Herzog, Evelyne Cohen, Ilana Karshai, David BenEzra.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17420393     DOI： 10.1001/archopht.125.4.580

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  7 in total

Review 1.  [The latest on amblyopia treatment].

Authors:  O Ehrt
Journal:  Ophthalmologe       Date:  2008-05       Impact factor: 1.059

Review 2.  The treatment of amblyopia: current practice and emerging trends.

Authors:  Eleni Papageorgiou; Ioannis Asproudis; Gail Maconachie; Evangelia E Tsironi; Irene Gottlob
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-01-31       Impact factor: 3.117

3.  A pilot randomized clinical trial of intermittent occlusion therapy liquid crystal glasses versus traditional patching for treatment of moderate unilateral amblyopia.

Authors:  Jingyun Wang; Daniel E Neely; Jay Galli; Joshua Schliesser; April Graves; Tina G Damarjian; Jessica Kovarik; James Bowsher; Heather A Smith; Dana Donaldson; Kathryn M Haider; Gavin J Roberts; Derek T Sprunger; David A Plager
Journal:  J AAPOS       Date:  2016-07-12       Impact factor: 1.220

Review 4.  [Treatment monitoring and innovations in amblyopia treatment].

Authors:  Kai Januschowski; Caroline Emmerich; Annegret Abaza; Henrike Julich-Haertel; Annekatrin Rickmann
Journal:  Ophthalmologe       Date:  2019-12       Impact factor: 1.059

5.  Monitoring of wearing and occlusion times with smart shutter glasses-A proof of concept.

Authors:  Frank R Ihmig; Kai Januschowski; Timo Koch; Thomas Velten; Annekatrin Rickmann
Journal:  PLoS One       Date:  2022-06-24       Impact factor: 3.752

6.  Current concepts in the management of amblyopia.

Authors:  Blanca Ruiz de Zárate; Jaime Tejedor
Journal:  Clin Ophthalmol       Date:  2007-12

7.  Intense versus standard regimens of intermittent occlusion therapy for unilateral moderate amblyopia in children: study protocol for a randomized controlled trial.

Authors:  Jingyun Wang; Ayesha Malik; Jing Jin; Yi Pang; Kelly Yin; Megan Allen; Adriana Grigorian; Brandy Scombordi; Joann Bailey; Saeed Aljohani; Katharine Funari; Ruth Shoge; Siva Meiyeppen; Jenny Myung; Ajay Soni; Daniel E Neely
Journal:  Trials       Date:  2020-04-28       Impact factor: 2.279
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.